Hand holding a pill into the sky.

As a supplement to its well-known quarterly outlook report, Biomedtracker presents a longer-term look at some key late-stage drugs projected to hit the market in 2024. These drugs represent new drug classes, major changes to standards of care, and/or large market opportunities across the wide range of indications covered by Biomedtracker and Datamonitor Healthcare.

Related resources

PDF preview of the 2024 Pharmaceutical Industry Predictions by Citeline.
JAN 11, 2024
ニュース記事
研究開発支援サービス

The Pharmaceutical Industry: 2024 (and Beyond) Predictions

This year we can expect many recurring themes in the pharmaceutical industry, including AI, decentralized clinical trials and a call for greater diversity.

concerns-and-hopes-for-health-care-2024-resource-card-thumbnail
NOV 29, 2023
ニュース記事
商業化支援サービス

Concerns and Hopes for Health Care Delivery in 2024

Life sciences companies will face a number of challenges in the coming year. Industry experts from across Norstella shared their concerns going into 2024.